|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 1/19/18 NowRx, Inc. 1-A 7:1.9M Toppan Vintage/FA |
Document/Exhibit Description Pages Size 1: 1-A Offering Statement -- Reg. A -- primary_doc.xml HTML 18K 2: PART II AND III Parts II & III -- Form 1-A HTML 426K 3: EX1A-1 UNDR AGMT Exhibit 1 HTML 24K 4: EX1A-2A CHARTER Exhibit 2.1 HTML 14K 5: EX1A-2B BYLAWS Exhibit 2.3 HTML 99K 6: EX1A-4 SUBS AGMT Exhibit 4.2 HTML 50K 7: EX1A-11 CONSENT Exhibit 11 HTML 6K
Exhibit 11
802 N Washington St
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in the Offering Statement on Form 1-A of our report dated December 27, 2017, on the balance sheets of NowRx, Inc. as of December 31, 2016 and 2015, and the related statements of operations, changes in stockholders’ equity (deficit), and cash flows for each of the years then ended, and the related notes to the financial statements. Our report contains an explanatory paragraph regarding NowRx, Inc.’s ability to continue as a going concern.
 |
|
| Fruci & Associates II, PLLC | |
| Spokane, Washington | |
| January 19, 2018 |
| This ‘1-A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 1/19/18 | None on these Dates | ||
| 12/27/17 | ||||
| 12/31/16 | ||||
| 12/31/15 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/28/22 NowRx, Inc. 1-SA 6/30/22 3:946K Toppan Merrill/FA 5/02/22 NowRx, Inc. 1-K 12/31/21 3:1.4M Toppan Merrill/FA 9/27/21 NowRx, Inc. 1-A/A 7:15M Toppan Merrill/FA 8/10/21 NowRx, Inc. 1-A 9:1.8M Toppan Merrill/FA 4/30/21 NowRx, Inc. 1-K 12/31/20 2:788K Toppan Merrill/FA 9/25/20 NowRx, Inc. 1-SA 6/30/20 2:696K Toppan Merrill/FA 3/22/18 SEC UPLOAD¶ 4/27/18 1:42K NowRx, Inc. 3/09/18 SEC UPLOAD¶ 4/27/18 1:139K NowRx, Inc. 2/08/18 SEC UPLOAD¶ 4/27/18 1:246K NowRx, Inc. |